Search
Remlifanserin
go.drugbank.com/drugs/DB21707ExperimentalRemlifanserin is a small molecule drug. The usage of the INN stem '-anserin' in the name indicates that Remlifanserin is a serotonin receptor antagonist. … Remlifanserin has a monoisotopic molecular weight of 429.22 Da.
Envudeucitinib
go.drugbank.com/drugs/DB21716InvestigationalEnvudeucitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Envudeucitinib is a Janus kinase inhibitor. … Envudeucitinib has a monoisotopic molecular weight of 426.23 Da.
Zemprocitinib
go.drugbank.com/drugs/DB21719ExperimentalZemprocitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Zemprocitinib is a Janus kinase inhibitor. … Zemprocitinib has a monoisotopic molecular weight of 345.13 Da.
SRD-001
go.drugbank.com/drugs/DB25902InvestigationalSRD-001 is a biologic drug. … SRD-001 is under investigation in clinical trial NCT06224660 (Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy).
Drostanolone
go.drugbank.com/drugs/DB00858ExperimentalIllicitDrostanolone is indicated in postmenopausal women with recurrent breast cancer, in a combined hormone therapy. … Drostanolone (also known as dromostanolone) is a potent synthetic androgenic anabolic steroid similar to testosterone.
Synonyms: 17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-oneHypoxanthine
go.drugbank.com/drugs/DB04076InvestigationalHypoxanthine is a purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.
Categories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 2-RingAnsofaxine
go.drugbank.com/drugs/DB15052InvestigationalAnsofaxine is under investigation in clinical trial NCT02271412 (Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005).
Zimlovisertib
go.drugbank.com/drugs/DB15143InvestigationalPF-06650833 is under investigation in clinical trial NCT02609139 (Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects).
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingQuilizumab
go.drugbank.com/drugs/DB15176InvestigationalQuilizumab is under investigation in clinical trial NCT01160861 (A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis).
Gosuranemab
go.drugbank.com/drugs/DB15376InvestigationalGosuranemab is under investigation in clinical trial NCT02460094 (Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy).